Author

O. Mirabeau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Surdez· 2 shared M.-M. Aynaud· 2 shared O. Delattre· 2 shared A. Anisimov· 1 shared A. Marchetto· 1 shared A. Oldner· 1 shared A. Osman· 1 shared A. Shlien· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Surdez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 - implications for microvascular inflammation and hypercoagulopathy in COVID-19

L. He, M. A. Mae, L. Muhl, Y. Sun, R. Pietila, K. Nahar, E. V. Liebanas, M. J. Fagerlund, A. Oldner, J. Liu, G. Genove, L. Zhang, Y. Xie, S. Liptidis, G. Mocci, , C. Betsholtz

The paper shows that pericytes, not endothelial cells, express ACE2 in microvessels, suggesting they may be infected in COVID-19 and contribute to microvascular inflammation and hypercoagulopathy.

bioRxiv · May 11, 2020 · PreprintPathology

Cooperation of dominant oncogenes with regulatory germline variants shapes clinical outcomes in childhood cancer

J. Musa, F. Cidre-Aranaz, M.-M. Aynaud, M. F. Orth, O. Mirabeau, M. Varon, S. Grossetete, D. Surdez, S. Ohmura, J. S. Gerke, A. Marchetto, M. Dallmayer, M. C. Baldauf, M. Gartlgruber, F. Westermann, , T. G. P. Grunewald

This study shows how a dominant oncogene and regulatory germline variants together influence tumor growth, survival, and drug response in Ewing sarcoma.

Nature Communications · Sep 11, 2019Peer-reviewedCancer Biology

Transcriptional programs define intratumoral heterogeneity of Ewing sarcoma at single cell resolution

M.-M. Aynaud, O. Mirabeau, N. Gruel, S. Grossetete-Lalami, V. Boeva, S. Durand, D. Surdez, O. Saulnier, S. Zaidi, S. Gribkova, U. Kairov, V. Raynal, F. Tirode, T. G. Grunewald, M. Bohec, , A. Zinovyev

This study identifies transcriptional programs driving intratumoral heterogeneity in Ewing sarcoma using single-cell RNA-sequencing and chromatin analysis.

bioRxiv · Apr 30, 2019Cancer Biology